Compare DexCom, Inc. (DXCM) vs iShares Russell 2000 ETF (IWM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs iShares Russell 2000 ETF — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while iShares Russell 2000 ETF trades at $278.93 (market cap $77.70B). The key difference: iShares Russell 2000 ETF is far larger — about 2.4× DexCom, Inc.'s market cap, and DexCom, Inc. is trading nearer its 52-week high, iShares Russell 2000 ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and iShares Russell 2000 ETF for 83 Days on average.
| DXCM | IWM | |
|---|---|---|
Market Cap | $31.86B | $77.70B |
Volume | 3,607,070 | 35,598,983 |
Sector | Health | — |
52-Week High | $92.34 | $305.06 |
52-Week Low | $54.84 | $229.13 |
Typical Hold Time | 62 Days | 83 Days |
Enterprise Value | $31.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth, reaching $4.66 billion in 2025. Technical indicators show a bearish short-term trend with key support at $82. The company maintains impressive profitability with 20.12% net margins and 38.49% ROE, supported by growing adoption of CGM technology in diabetes care.
DXCM presents a compelling growth story with expanding market opportunities in Type 2 diabetes care. Analyst consensus remains strongly bullish with 81% buy ratings and $95.07 price target, suggesting 13% upside. Key risks include reimbursement challenges and competitive pressures. The company's strong cash flow generation and institutional support provide solid foundation for continued growth.
IWM trades at $277.63, showing minimal daily movement with a slight decline of 0.03%. Technical indicators signal a bearish trend with moving averages and ADX pointing downward, while oscillators remain neutral. The ETF faces headwinds from Federal Reserve rate hike concerns and underperformance relative to large-cap indices. Recent institutional selling and negative media coverage highlight ongoing challenges for small-cap exposure.
The outlook remains cautious as small-caps face pressure from tightening financial conditions and energy price volatility. While offering diversification from tech-heavy indices, IWM's inclusion of unprofitable companies and decade-long underperformance versus the S&P 500 present significant hurdles for near-term outperformance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About iShares Russell 2000 ETF
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →
